Nivolumab maintenance in high-risk acute myeloid leukemia patients: a single-arm, open-label, phase II study.
Patrick K RevilleHagop M KantarjianFarhad RavandiElias JabbourCourtney D D DiNardoNaval DaverNaveen PemmarajuMaro OhanianYesid AlvaradoLianchun XiaoGheath AlatrashSanam LoghaviCaitlin R RauschGautam BorthakurMarina Y KonoplevaJorge E CortesTapan Mahendra KadiaPublished in: Blood cancer journal (2021)
Keyphrases
- phase ii study
- open label
- acute myeloid leukemia
- end stage renal disease
- ejection fraction
- newly diagnosed
- clinical trial
- chronic kidney disease
- peritoneal dialysis
- study protocol
- randomized controlled trial
- phase iii
- squamous cell carcinoma
- patient reported outcomes
- allogeneic hematopoietic stem cell transplantation
- placebo controlled
- double blind